Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-19

FDA Approved: ATORVASTATIN CALCIUM — Original Application (Cipla USA Inc.,)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s atorvastatin calcium tablet as an Original Application, enabling a generic atorvastatin calcium product to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

ORIG AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)